Research use only · Lyophilised material · Not a medicine · Not for human or veterinary use · Disclaimer

Research Peptide Storage: What the Laboratory Literature Says

Research Peptide Storage: What the Laboratory Literature Says is supplied for laboratory research only. Key facts are below; stored as lyophilised powder.

Last verified 12 Oct 2026.

A CoA for every lot; each vial carries a printed lot number that matches it. Ask with the lot number and we send it.

The short answer

Published laboratory guidance describes dry (lyophilised) peptides as most stable kept dry, cool and dark, with -20 °C preferred for long-term storage, and notes that moisture greatly reduces the long-term stability of the solid [1]. Peptides in solution are described as having a limited shelf life [1]. This page summarises the literature; it is not a Sable Peptides storage schedule.

Research use only. Sable Peptides supplies laboratory reagents for in vitro and laboratory research by qualified people. Not a medicine. Not for human or veterinary use.

The short answer

Published laboratory guidance describes dry (lyophilised) peptides as most stable kept dry, cool and dark, with -20 °C preferred for long-term storage, and notes that moisture greatly reduces the long-term stability of the solid [1]. Peptides in solution are described as having a limited shelf life [1]. This page summarises the literature; it is not a Sable Peptides storage schedule.

The chemistry behind the guidance

Peptides degrade through a small set of well-described routes [3][4]: - Hydrolysis of peptide bonds, notably at Asp–Pro sites. - Deamidation of asparagine and glutamine [6]. - Oxidation of methionine, cysteine, tryptophan and histidine, accelerated by light, metal ions and peroxides [5]. - Aggregation and adsorption, mainly in solution [3]. These reactions generally slow at lower temperature and lower water content, which is why solid-state reviews link stability of dry peptides to residual moisture and temperature [2].

Dry (lyophilised) material in the literature

- Guidance describes dry, cool and dark conditions, 4 °C or colder, with -20 °C preferred for long-term storage [1]. - Moisture is described as greatly decreasing the long-term stability of solid peptides [1][2]. - Guidance notes that a vial is allowed to reach room temperature before opening, so condensation does not form, and that resealing under dry inert gas is preferred [1]. - Low residual moisture in a well-formed lyophilised cake is a main reason it keeps well [7].

Peptides in solution in the literature

- Solutions are less stable than the dry solid, because water enables hydrolysis, deamidation and oxidation [3]. - Guidance describes solution shelf life as limited, especially for sequences containing Cys, Met, Asn, Gln or Trp, and lists frozen storage at -20 °C or colder [1]. - Repeated freezing and thawing is described as deleterious, and frost-free freezers as unsuitable because their temperature varies during defrosting [1]. - Peptides in solution can adsorb to vial surfaces, which matters most at high dilution [1].

What this page is not

It gives no storage schedule, no preparation method and no shelf-life figure for any product. The certificate of analysis for each lot is available for every lot.

- /ref/peptide-storage-stability - /learn/peptide-stability-and-shelf-life - /learn/lyophilisation-explained - /learn/bacteriostatic-water - /glossary

Sources

1. NIBSC. Peptide handling, dissolution and storage (CJD Resource Centre peptide library). nibsc.org/Default.aspx?pageid=428 2. Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. *J Pharm Sci* 1999;88:489-500. PMID 10229638. doi:10.1021/js980374e 3. Manning MC et al. Stability of protein pharmaceuticals: an update. *Pharm Res* 2010;27:544-75. PMID 20143256. doi:10.1007/s11095-009-0045-6 4. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. *Int J Pharm* 1999;185:129-88. PMID 10460913. doi:10.1016/s0378-5173(99)00152-000152-0) 5. Li S et al. Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. *Biotechnol Bioeng* 1995;48:490-500. PMID 18623513. doi:10.1002/bit.260480511 6. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. *J Biol Chem* 1987;262:785-94. PMID 3805008. 7. Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. *Pharm Res* 2004;21:191-200. PMID 15032301. doi:10.1023/b:pham.0000016234.73023.75

*Last reviewed: 2026-10-10. Original Sable Peptides content; general literature reference, not a preparation method or storage schedule. Sources verified via PubMed E-utilities, Crossref and live HTTP checks on 2026-10-10.*

Last reviewed: 2026-10-10

How much does Research Peptide Storage: What the Laboratory Literature Says cost in the UK?

Frequently asked questions

What temperature does the literature give for lyophilised peptides?

Published guidance describes 4 °C or colder for dry peptides, with -20 °C preferred for long-term storage, kept dry and dark [1].

Why does moisture matter for a dry powder?

Absorbed water increases molecular mobility in the solid and speeds hydrolysis and deamidation [2]. Guidance notes that cold vials are allowed to reach room temperature before opening to avoid condensation [1].

Are peptides in solution as stable as the powder?

No. Degradation reactions run much faster in solution, and guidance describes solution shelf life as limited [1][3].

Does light affect peptides?

Oxidation of residues such as tryptophan and methionine is accelerated by light, which is why dark storage appears in the guidance [1][5].

Does Sable Peptides publish a storage schedule?

No. This page summarises general literature. The certificate of analysis for each lot is available for every lot.